Uncategorized

The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of recurrence.

Right after reporting a major Phase 3 LAG-3 miss that has rattled analysts, Regeneron Pharmaceuticals revealed a back-loaded partnership with Parabilis Medicines aimed at adding a new drug class to its early-stage pipeline.

Providers are reaping high award amounts, and arbiters have “structural conflicts of interest” that incentivize a high volume of disputes, driving up healthcare costs for employers and patients, the groups wrote.

Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.

The sleep tracking industry is entering a new phase. For years, organizations have invested in programs expecting insight into recovery, productivity and risk. The wearable devices powering these programs have delivered capable hardware, yet user participation remains the variable that program ma…

The FDA has previously linked eight deaths in the U.S. to Tavneos and has alleged that doctored data were used to support the drug application that led to its approval in 2021.

The late-stage miss shakes analyst confidence in Regeneron’s clinical execution, according to BMO Capital Markets, also noting last year’s Phase 3 failure in chronic obstructive pulmonary disease.

After less than three weeks on the job, Katherine Szarama is being replaced by Karim Mikhail as acting head of the Center for Biologics Evaluation and Research. Mikhail had previously spent more than 20 years at Merck and joined the FDA last year.

Nusano will bring a massive new radioisotope facility in Salt Lake City online by the end of the year, establishing a supply of starting materials for the next generation of radiopharmaceuticals.

La historia de la ciencia está marcada por gigantes que, con frecuencia, operan lejos de los focos mediáticos. Edward Mills Purcell es uno de esos nombres imprescindibles. Galardonado con el Premio Nobel de Física en 1952, Purcell no solo transformó nuestra comprensi&oacu …